Rare manifestation of acute pulmonary edema associated with acute lupus myocarditis.

May 2012

[Article in English, Portuguese]

Soeiro AD, Bergamin FS, Almeida MC, Serrano Jr CV, Falcão BA, Ganem F.

Source

Instituto do Coração, HC, FM, USP, São Paulo, SP, Brasil.

Abstract

Systemic Lupus Erythematosus (SLE) is the most common systemic autoimmune disease, occurring more frequently in women, usually aged between 16 and 55 years1,2. Although classically the kidneys are the organs most affected in SLE, cardiopulmonary circulation and the heart may also be affected significantly3. In this context, the occurrence of acute pulmonary edema associated with lupus myocarditis is rare and specific immunosuppressive therapy remains unclear.

SciELO

Neurogenic Pulmonary Edema and Acute Respiratory Distress Syndrome in a Healthy Child With Febrile Status Epilepticus.

August 2012

Nguyen TT, Hussain E, Grimason M, Goldstein J, Wainwright MS.

Abstract

Neurogenic pulmonary edema is a clinical syndrome that manifests as an acute onset of pulmonary edema in the setting of a central nervous system injury, without cardiac dysfunction. Neurogenic pulmonary edema is rare in children, and the mechanism is still not completely understood. The clinical pathology overlaps with acute lung injury and acute respiratory distress syndrome. The authors report a case of a 14-month-old previously healthy child who presented with febrile status epilepticus, fulminant neurogenic pulmonary edema, and acute respiratory distress syndrome. Neurogenic pulmonary edema should be considered in the differential diagnosis for the rapid progression of respiratory failure following an acute neurological injury such as status epilepticus in a child. Prompt respiratory support and treatment of the acute neurological insult can prevent further cerebral hypoxemic injury.

SAGE Journals

Neurogenic pulmonary edema associated with underlying lung disease after a breakthrough seizure.

2012

Dutta G, Demetis S.

Source

Department of Internal Medicine, Lutheran Medical Center, 150 55th Street, Brooklyn, NY 11209, USA.

Abstract

Neurogenic pulmonary edema (NPE) can result from various central nervous system disorders such as brain malignancies, traumatic brain injuries, infections, and seizures. Although the pathogenesis is not completely understood, NPE creates an increase in pulmonary interstitial and alveolar fluid. It has been reported with prolonged seizure activity. Treatment for NPE is largely supportive. If unrecognized, it can lead to hypoxia and respiratory arrest. We report a case of NPE in a middle-aged female patient following a breakthrough seizure in whom an immunological cause for respiratory findings was high on the differential list, based on her past medical history and chronicity of symptoms. Rapid symptomatic and radiological improvement following hospitalization led to the correct diagnosis.

NIH

Efficacy of ANTISTAX in treatment of postmastectomic oedema of the upper limb.

2012

[Article in Russian]

Miasnikova MO.

Source

Chair of Faculty Surgery St. Petersburg State Medical University named after Academician I.P. Pavlov, St. Petersburg, Russia.

Abstract

Analysed herein are the results of two-year treatment with Antistax of 50 female patients presenting with early stages of upper limb lymphedema (the 'preclinical' stage of 'transient' oedemas, mild-oedema stage). The control group consisted of patients who due to various circumstances received no regular treatment with agents decreasing limb oedema, including diuretics. The obtained results demonstrated undoubted efficacy of Antistax administered at early stages of postmastectomic lymphedema. Preventive administration of the agent makes it possible to delay and in the majority of cases to also prevent the development of lymphedema. 

Administration of Antistax in a combination with physiotherapeutic treatment makes it possible both in the first and second stages of the disease to preserve the cosmetic and functional state of the upper limb.

PubMed

Effect of the 532nm pulsed KTP laser in the treatment of Reinke's edema.

Aug 2012

Pitman MJ, Lebowitz-Cooper A, Iacob C, Tan M.

Source

Voice and Swallowing Institute, Department of Otolaryngology, the Voice and Swallowing Institute, New York Eye & Ear Infirmary, New York, New York 10003, U.S.A.. mpitman@nyee.edu.

Abstract

OBJECTIVES/HYPOTHESIS:

To evaluate the effect and safety of the 532nm Pulsed Potassium-Titanyl-Phosphate (KTP) laser in the office-based treatment of patients with Reinke's edema using objective and subjective scaled outcome measures.

STUDY DESIGN:

Case Series.

SETTING:

Tertiary hospital center.

SUBJECTS:

Seven adult females undergoing in-office KTP laser treatment for  Reinke's edema.

METHODS:

Participants were studied pre- and posttreatment. Vocal function was evaluated by objective aerodynamic and acoustic analysis. Subjective changes were evaluated using the GRBAS scale, Voice Handicap Index, and videostroboscopy. Histologic effects of the laser were investigated by comparing one patient treated with laser one year prior to excision, one treated with laser just prior to excision, and one control patient who underwent excision without prior laser treatment.

RESULTS:

At an average postoperative follow up of 17.8 weeks (range 5-78), maximum phonation time trended toward improvement. The median VHI score decreased from 37 to 26 (p=0.150). There was a reduction in each component of the GRBAS scoring and the median fundamental frequency increased from 162 to 186 (p=0.625). Stroboscopic findings demonstrated an intact posttreatment mucosal wave. Histologic comparison of the tissue effects of laser in three patients demonstrated changes in vocal fold vascularity but no acute or long-term damage to the overlying epithelium.

CONCLUSION:

Objective and subjective scaled measures suggest that treatment of Reinke's edema in the office with a 532nm KTP laser may result in improved voice. It appears safe with histologic preservation of the vocal fold vibratory epithelium and persistence of mucosal wave. Laryngoscope, 2012.

Wiley Online Library

15th Annual State of GA Lymphedema Education Program

Winship Cancer Institute of Emory University

and The Lighthouse Lymphedema Network

Cordially invite you to the

15th State of Georgia Lymphedema Education & Awareness Conference

Saturday, October 27, 2012

Emory University Hospital Midtown, 550 Peachtree Street, Atlanta, GA 30308

7:30am-4:30pm

Speakers include: Jane Armer, PhD, Richard Mistretta, DPM,

Joseph Feldman, MD, and David W. Chang, MD

The Conference Brochure may be viewed by clicking here:

http://lighthouselymphedema.org/announcements/15th-annual-state-of-georgia-lymph\
edema-education-and-awareness-program

You may register online by clicking here:

http://lighthouselymphedema.org/get-involved/secureregistration.htm

INFO PAGE:

http://lighthouselymphedema.org/announcements/15th-annual-state-of-georgia-lymph\
edema-education-and-awareness-program